Cargando…

Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme

BACKGROUND: Transforming growth factor beta-induced (TGFBI) protein has been found expressed in several cancer types, and expression levels of TGFBI can affect the cancer patients’ outcomes, but the role of TGFBI in glioblastoma multiforme (GBM) remains obscure. METHODS: The TGFBI expression levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Jun, Liu, Jin-Song, Feng, Mei, Li, Jiao-Ming, Lu, Shun, Yang, Mu, Cao, Bang-Rong, Lang, Jin-Yi, Zhu, Xiao-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798009/ https://www.ncbi.nlm.nih.gov/pubmed/35117257 http://dx.doi.org/10.21037/tcr-20-2906

Ejemplares similares

Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Genotypic Homogeneity in Distinctive Transforming Growth Factor-Beta Induced (TGFBI) Protein Phenotypes
por: Han, Sang Beom, et al.
Publicado: (2021)

Investigation of TGFBI (Transforming growth factor beta-induced) Gene Mutations in Families with Granular Corneal Dystrophy Type 1 in the Konya Region
por: Malkondu, Fatma, et al.
Publicado: (2020)

TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023)

Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC)
por: Du, Guo-Wei, et al.
Publicado: (2020)

Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report
por: Hsu, Bing-Hung, et al.
Publicado: (2020)

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
por: Chen, Anjing, et al.
Publicado: (2022)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
por: Li, Hao, et al.
Publicado: (2021)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics
por: Li, Rui, et al.
Publicado: (2015)

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017)

ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
por: Tumbarello, David A, et al.
Publicado: (2012)

SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells
por: Tumbarello, David A., et al.
Publicado: (2016)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review
por: Pepper, Niklas Benedikt, et al.
Publicado: (2022)

Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C
por: Steitz, Anna Mary, et al.
Publicado: (2020)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

A Multi-Element Expression Score Is A Prognostic Factor In Glioblastoma Multiforme
por: Li, Jun-Qi, et al.
Publicado: (2019)

Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
por: Ween, Miranda P., et al.
Publicado: (2012)

Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene
por: Karring, Henrik, et al.
Publicado: (2007)

Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme
por: Zhu, Yi-Fang, et al.
Publicado: (2019)

Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study
por: Șerban, Georgiana, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rg41cbjqirk7kh9mbk63lpmhi